4dmedical USA INC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$449Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
26clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2023 $215K
2024 $233K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Internal Medicine $258K
Hematology & Oncology $108K
Diagnostic Radiology $65K
Pulmonary Disease $17K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
David Shulkin Morristown, NJ Internal Medicine $258,398.17
Robert Figlin Duarte, CA Hematology & Oncology $108,485.58
Geraldine Mcginty New York, NY Diagnostic Radiology $55,669.96
Raymond Casciari Orange, CA Pulmonary Disease $16,171.70
Greg Mogel Los Angeles, CA Diagnostic Radiology $8,625.00
Trishul Siddharthan Miami, FL Pulmonary Disease $142.05
Naresh Punjabi Miami, FL Pulmonary Disease $139.99
Myron Kung North Las Vegas, NV Pulmonary Disease $139.86
Douglas Hogarth Chicago, IL Pulmonary Disease $114.66
Joseph Cicenia Cleveland, OH Pulmonary Disease $95.61

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.